Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Meribel Pharma Solna AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 9,082 More Arrow 10,821 Less Arrow 8,398
Financial expenses 271 Less Arrow 262 Less Arrow 145
Earnings before taxes -1,706 More Arrow 879 Less Arrow -724
EBITDA -1,380 More Arrow 1,225 Less Arrow -409
Total assets 6,407 Less Arrow 5,930 Less Arrow 4,405
Current assets 4,866 Less Arrow 4,489 Less Arrow 2,778
Current liabilities 3,204 Less Arrow 2,950 Less Arrow 1,988
Equity capital 3,203 Less Arrow 2,980 Less Arrow 2,416
- share capital 4 More Arrow 5 Less Arrow 4
Employees (average) 73 Less Arrow 69 Less Arrow 62

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 50.0% More Arrow 50.3% More Arrow 54.8%
Turnover per employee 124 More Arrow 157 Less Arrow 135
Profit as a percentage of turnover -18.8% More Arrow 8.1% Less Arrow -8.6%
Return on assets (ROA) -22.4% More Arrow 19.2% Less Arrow -13.1%
Current ratio 151.9% More Arrow 152.2% Less Arrow 139.7%
Return on equity (ROE) -53.3% More Arrow 29.5% Less Arrow -30.0%
Change turnover -1,371 More Arrow 2,398 Less Arrow -606
Change turnover % -13% More Arrow 28% Less Arrow -7%
Chg. No. of employees 4 More Arrow 7 Less Arrow -2
Chg. No. of employees % 6% More Arrow 11% Less Arrow -3%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.